(ONMD) OneMedNet - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock •
ONMD: Clinical, Imaging, Solutions, AI, Data, Analytics, Software
OneMedNet Corporation specializes in clinical imaging solutions, addressing the challenges of data silos and secure sharing in healthcare. Their iRWD platform leverages AI to anonymize and manage imaging data, crucial for compliance with regulations like HIPAA, enabling medical and academic institutions to advance research and diagnostics.
Based in Eden Prairie, Minnesota, OneMedNet operates in the Health Care Technology sector under the ticker ONMD on NASDAQ. Their solutions facilitate efficient data management, enhancing collaboration and innovation in life sciences.
Web URL: https://www.onemednet.com
3-Month Forecast: Technically, ONMD is below its 20, 50, and 200-day SMAs, suggesting a bearish trend. A break above the 20-day SMA at 0.91 could signal a potential reversal. The ATR of 0.10 indicates low volatility, expecting small price movements. Fundamentally, the high P/E ratio of 90.95 reflects market expectations for growth, though the lack of forward P/E and high P/S ratio of 29.04 suggest risk. The RoE of 182.25 indicates profitability but may also point to a small equity base. The low market cap of $27.81M adds to the speculative nature of the investment.
Additional Sources for ONMD Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ONMD Stock Overview
Market Cap in USD | 28m |
Sector | Healthcare |
Industry | Health Information Services |
GiC Sub-Industry | Health Care Technology |
IPO / Inception | 2023-11-08 |
ONMD Stock Ratings
Growth 5y | -49.6% |
Fundamental | 19.6% |
Dividend | 0.0% |
Rel. Strength Industry | -18.3 |
Analysts | - |
Fair Price Momentum | 0.54 USD |
Fair Price DCF | 4.23 USD |
ONMD Dividends
No Dividends PaidONMD Growth Ratios
Growth Correlation 3m | -60.6% |
Growth Correlation 12m | 23.6% |
Growth Correlation 5y | -46.7% |
CAGR 5y | -51.04% |
CAGR/Max DD 5y | -0.53 |
Sharpe Ratio 12m | -1.14 |
Alpha | -13.43 |
Beta | -1.29 |
Volatility | 120.31% |
Current Volume | 16.7k |
Average Volume 20d | 40.7k |
As of March 16, 2025, the stock is trading at USD 0.69 with a total of 16,667 shares traded.
Over the past week, the price has changed by -7.86%, over one month by -25.67%, over three months by -25.54% and over the past year by -17.62%.
Neither. Based on ValueRay Fundamental Analyses, OneMedNet is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 19.55 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ONMD as of March 2025 is 0.54. This means that ONMD is currently overvalued and has a potential downside of -21.74%.
OneMedNet has no consensus analysts rating.
According to ValueRays Forecast Model, ONMD OneMedNet will be worth about 0.6 in March 2026. The stock is currently trading at 0.69. This means that the stock has a potential downside of -14.49%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 0.6 | -14.5% |